Health In Tech, Inc. 8-K

What Happened

• On March 25, 2026, Health In Tech, Inc. (HIT) announced it entered a securities purchase agreement with accredited investors for a private investment in public equity (PIPE) of 5,600,000 shares of common stock, expected to generate gross proceeds of approximately $7.0 million. The transaction is expected to close on or about March 27, 2026, subject to customary conditions. Craig‑Hallum Capital Group LLC is serving as sole placement agent.

Key Details

• Shares: 5,600,000 shares of HIT common stock.
• Expected gross proceeds: approximately $7.0 million (before placement agent fees and offering expenses).
• Timing & obligations: expected close on/around March 27, 2026; the company agreed to file a resale registration statement within 30 days and keep it effective until resale conditions are met.
• Terms: issuance is exempt from registration under Section 4(a)(2) and/or Rule 506(b); placement agent fees and a 60‑day director/officer lock-up (after registration effectiveness) apply.

Why It Matters

• The financing provides near-term capital the company says it will use to expand sales distribution, advance technology and new product development, and support general working capital. For investors, the PIPE means dilution because new shares are being issued; registration of the resale shares will enable those investors to sell once registration is effective or Rule 144 conditions are met. Placement agent fees and offering expenses will reduce net proceeds.